Tag: Gilead HIV vaccine trial results
Twice-Yearly HIV Shot by Gilead Reduces Infections by 96%
Gilead Sciences, a leading pharmaceutical company, has announced groundbreaking results from a second large study on their twice-yearly HIV prevention injectable drug, lenacapavir. According...